Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019

Meera Dhodapkar, Audrey D. Zhang, Jeremy Puthumana, Nicholas S. Downing, Nilay D. Shah, Joseph S. Ross

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019'. Together they form a unique fingerprint.

Medicine & Life Sciences